MedTrace Logo

A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI

NCT06465901 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10092

Last updated 2024-06-20

No results posted yet for this study

Summary

MARLIN is a stratified, multi-arm, multi-stage factorial randomised platform trial aiming to reduce the incidence of post-operative surgical site infection (SSI).

Conditions

  • Surgical Site Infection

Interventions

OTHER

Chlorhexidine Gluconate 2.0% to 4.0% (e.g. Hibiscrub) preoperative shower

Chlorhexidine Gluconate 2.0% to 4.0% (e.g. Hibiscrub) preoperative shower

OTHER

Intraoperative wound wash (e.g. Granudacyn)

Intraoperative wound wash (e.g. Granudacyn)

OTHER

DACC surgical wound dressing (e.g. Leukomed Sorbact)

DACC surgical wound dressing (e.g. Leukomed Sorbact)

Sponsors & Collaborators

  • Kigali University Teaching Hospital

    collaborator OTHER

  • Université d'Abomey-Calavi

    collaborator OTHER

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Thomas Pinkney · University of Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2026-08-31
Completion
2026-09-30

Countries

  • Benin
  • Ghana
  • India
  • Mexico
  • Nigeria
  • Rwanda
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06465901 on ClinicalTrials.gov